Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00481728
What this trial is testing

Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.

Who this might be right for
Overactive Bladder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 28
Large-scale testing (Phase 3)Study completedNCT00608322
What this trial is testing

Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis

Who this might be right for
Sepsis
National Institute of General Medical Sciences (NIGMS) 49
Not applicableUnknownNCT04317157
What this trial is testing

Placebo Effects Investigated by Different Experimental Designs

Who this might be right for
CaffeinePlaceboBaseline
University of Sao Paulo 18
Early research (Phase 1)Study completedNCT06476275
What this trial is testing

Single Dose Texas 2017 (H3N2) Challenge Study

Who this might be right for
Influenza Viral Infections
Duke University 33
Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8
Post-approval studies (Phase 4)Study completedNCT01902004
What this trial is testing

Brain Aging and Treatment Response in Geriatric Depression

Who this might be right for
Mild Cognitive Impairment (MCI)Depression
University of California, Los Angeles 115
Large-scale testing (Phase 3)Study completedNCT00101634
What this trial is testing

Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 518
Testing effectiveness (Phase 2)Study completedNCT03813199
What this trial is testing

Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abivax S.A. 60
Early research (Phase 1)Study completedNCT06721091
What this trial is testing

Safety, Tolerability, and Dose Response of VNA-318 in Healthy Males

Who this might be right for
Healthy Volunteer
VANDRIA 92
Early research (Phase 1)Study completedNCT05136690
What this trial is testing

Evoked Responses as Pharmacodynamic Biomarkers in Healthy and Schizophrenic Participants (MK-4334-007)

Who this might be right for
Cognitive Impairment Associated With Schizophrenia
Merck Sharp & Dohme LLC 38
Testing effectiveness (Phase 2)Study completedNCT00638755
What this trial is testing

The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis

Who this might be right for
Perennial Allergic Rhinitis
Capnia, Inc. 20
Large-scale testing (Phase 3)Study completedNCT00545740
What this trial is testing

Prevention of Recurrence of Diverticulitis

Who this might be right for
Diverticulitis
Shire 590
Testing effectiveness (Phase 2)Study completedNCT04470050
What this trial is testing

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal

Who this might be right for
Opioid Withdrawal
BioXcel Therapeutics Inc 225
Large-scale testing (Phase 3)Study completedNCT00428090
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 862
Testing effectiveness (Phase 2)Looking for participantsNCT07215702
What this trial is testing

Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

Who this might be right for
SepsisAcute Kidney Injury
AstraZeneca 124
Not applicableStudy completedNCT01501747
What this trial is testing

The Placebo Effect May Involve Modulating Drug Bioavailability

Who this might be right for
Placebo EffectDrug Half LifePharmacokinetics
King Faisal Specialist Hospital & Research Center 162
Large-scale testing (Phase 3)Study completedNCT01710358
What this trial is testing

A Study in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 1,307
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Not applicableStudy completedNCT04580563
What this trial is testing

Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study

Who this might be right for
Septic ShockCoagulopathyDisseminated Intravascular Coagulation
University Hospital, Strasbourg, France 60
Not applicableStudy completedNCT02073214
What this trial is testing

Effects of Oral Probiotic Supplementation on the Clinical Status of Very-low-birth-weight Preterm Neonates.

Who this might be right for
Late Onset Neonatal SepsisNecrotizing EnterocolitisInfant, Very Low Birth Weight
IBSS Biomed S.A. 182
Next Page